Related posts
Markets weaken despite earnings beats3 Fast Food Stocks to Nibble OnPEP and NVDA: 3 More Top Recognized ESG Investing OptionsThis summary was created by AI, based on 9 opinions in the last 12 months.
PepsiCo (PEP-Q) has reported a mixed performance for Q3, with revenue growth and food and beverage sales volume coming in below expectations. However, the company has reiterated its full-year earnings growth and plans to add automation to cut costs and expand into healthier snacks. The stock has shown resilience and is considered a good defensive stock within the beverage and snack food sector. There are concerns about consumer revolt on price increases and impact of weight-loss drugs, but overall, the company is executing well and has strong brand recognition.
Before they reported early yesterday, several analysts were downgrading it, based on lowering organic growth forecasts, concerns over Frito-Lay, weakness in North America, and others. Results: 1.3% revenue growth vs. 2.7% expected, and -2% food and beverage sales volume. No surprise, so shares actually closed higher by the end of the day. Highlights of Q3: Gatorade gained market share, and core operating expanded 90 basis points despite more spending on ads. Pepsi reiterated full-year earnings growth of 8%. They will add more automation to cut costs and add healthier snacks. The street expected a bad quarter, so it sold off, but the quarter wasn't that bad.
The boring name in his portfolio. Yield is 3.1%, very secure, will grow around 6% over time. Very steady name, moving higher. With interest rates starting to fall, low-beta names like this will become more attractive. Paying 21x forward PE for 8% growth rate, not too bad. For the conservative part of your equity portfolio. 80% of shares are institutionally owned, so the smart money's in this stock.
It has been a great company for the past 40 years. There has been a consumer revolt on price increases. The growth rate is flat to down in the short term.
Great company. Smart to expand into snacks, unlike KO, gives diversification. Executes very well. Issue is valuation, 25+ PE range. As a value investor, not interested. Not sure the Ozempic craze is a threat, need to see ramifications.
OK, doesn't love it. Earnings were light in some sectors, but showed some resilience overall. Range-bound, kicking its way up. Consumer weaker right now, so he doesn't like consumer discretionary as much. Strong brand recognition, one of the better names in the space.
It reports Friday. Shares have been in a rut even though business is pretty good. He thinks people are worried about the impact of the hit weight-loss drugs.
Consumer products are facing pressure around the world. Don't sell just for tax reasons. Instead, ask yourself is the original thesis for why you wanted to own a stock still valid? If not, let it go. What you choose to buy instead is a separate decision.
We would be a bit agnostic on a name like PEP. It is large and stable and grows at mid-single digits but also trades at 20X forward earnings and should have tough comparable numbers over the next year, coming off of inflation pass through benefits. We think it would be fine for a 'steady eddie' type of name over the long term but also not something that excites us a whole lot.
Unlock Premium - Try 5i Free
The valuation has always been too high, and its growth is slow.
It reports on Tuesday. The market is killing all food stocks, and PEP is saddled with the stigmna of producing junk food when obesity (given the new obesity drugs) is on people's minds. Shares have fallen lately, but he expects good earnings near-term. Sells at a not-cheap 21x PE and pays a 3.2% dividend, which is low verses the bond market. Without growth, shares will fall.
Great chart over 10+ years. Lower beta than the S&P 500. Leading global consumer powerhouse with a diverse portfolio of well-known brands. Stepping into healthier acquisitions.
Very strong balance sheet, robust cashflow, giving you a reliable dividend. More share buybacks to come. A name for reliable growth with income. Yield is 2.80%, expected to grow about 7%.
PepsiCo is a American stock, trading under the symbol PEP-Q on the NASDAQ (PEP). It is usually referred to as NASDAQ:PEP or PEP-Q
In the last year, 7 stock analysts published opinions about PEP-Q. 4 analysts recommended to BUY the stock. 2 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for PepsiCo.
PepsiCo was recommended as a Top Pick by on . Read the latest stock experts ratings for PepsiCo.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
7 stock analysts on Stockchase covered PepsiCo In the last year. It is a trending stock that is worth watching.
On 2024-11-20, PepsiCo (PEP-Q) stock closed at a price of $158.74.
Our PAST TOP PICK with PEP has triggered its stop at $162. To remain disciplined, we recommend covering the position at this time.